Injective (INJ) price has been on a 48% tear since Blackrock filed a Bitcoin ETF application with the SEC on June 15. On-chain data shows that long-term investors are doubling down on their bullish positions.
Injective (INJ) price has been on a 48% tear since Blackrock filed a Bitcoin ETF application with the SEC on June 15. On-chain data shows that long-term investors are doubling down on their bullish positions.